Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Wang

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medical Economics|November 28, 2014
Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United StatesNing Wu, Yanni F Yu, Chien-Chia Chuang, et al.
Open Forum Infectious Diseases|June 15, 2019
Antimicrobial Resistance or Delayed Appropriate Therapy-Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?Thomas P Lodise, Ariel Berger, Arman Altincatal, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2024
Impact of diagnostic coding schemas on major bleeding risk assessment for oral anticoagulants in patients with atrial fibrillation using administrative claims dataHsiu-Ting Chien, Tze-Fan Chao, Rosa Wang, et al.
Cardiology and Therapy|May 3, 2023
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial FibrillationGiuseppe Patti, Rosa Wang, Xiaocong Li Marston, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary FibrosisYanni F Yu, Ning Wu, Chien-Chia Chuang, et al.
The American Journal of Cardiology|January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
The American Journal of Cardiology|October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2026
Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use ComparisonAngel Valladares, Joseph Imperato, Sidharth Gupta, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medical Economics|November 28, 2014
Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United StatesNing Wu, Yanni F Yu, Chien-Chia Chuang, et al.
Open Forum Infectious Diseases|June 15, 2019
Antimicrobial Resistance or Delayed Appropriate Therapy-Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?Thomas P Lodise, Ariel Berger, Arman Altincatal, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2024
Impact of diagnostic coding schemas on major bleeding risk assessment for oral anticoagulants in patients with atrial fibrillation using administrative claims dataHsiu-Ting Chien, Tze-Fan Chao, Rosa Wang, et al.
Cardiology and Therapy|May 3, 2023
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial FibrillationGiuseppe Patti, Rosa Wang, Xiaocong Li Marston, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary FibrosisYanni F Yu, Ning Wu, Chien-Chia Chuang, et al.
The American Journal of Cardiology|January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
The American Journal of Cardiology|October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2026
Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use ComparisonAngel Valladares, Joseph Imperato, Sidharth Gupta, et al.
Pageof 2